Highlights Human Metabolome Technologies, Inc.

Equities

6090

JP3794530000

Delayed Japan Exchange Other stock markets 11:30:00 29/05/2024 am IST			5-day change	1st Jan Change
641 ^JPY	-1.23%		-1.54%	+0.16%

2023	Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Year Ending June 30, 2024	CI
2023	Human Metabolome Technologies, Inc. Reports Earnings Results for the Nine Months Ended March 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Human Metabolome Technologies, Inc. Provides Dividend Guidance for the Year Ending June 2024	14/02	CI
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Year Ending June 30, 2024	10/23/10	CI
Human Metabolome Technologies, Inc. Announces Year End Dividend for the Year Ended June 30, 2023, Payable on September 7, 2023; Provides Year End Dividend Guidance for the Year Ending June 30, 2024	10/23/10	CI
Human Metabolome Technologies, Inc. Reports Earnings Results for the Nine Months Ended March 31, 2023	12/23/12	CI
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 2023	12/23/12	CI
Human Metabolome Technologies, Inc. Provides Dividend Guidance for the Year Ending June 2023	12/23/12	CI
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 30, 2023	14/23/14	CI
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Year Ending June 2023	11/22/11	CI
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Year Ending June 30, 2022	12/21/12	CI
Human Metabolome Technologies, Inc. Announces Consolidated Earnings Results for the Fourth Quarter Ended June 2021	13/21/13	CI
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Year Ending June 30, 2022	13/21/13	CI
Human Metabolome Technologies, Inc. Announces Consolidated Earnings Results for the Third Quarter Ended March 2021	12/21/12	CI
Human Metabolome Technologies, Inc. Announces Consolidated Earnings Results for the Second Quarter Ended December 2020	12/21/12	CI
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Year Ending June 30, 2021	12/21/12	CI
Human Metabolome Technologies, Inc. Announces Financial Results for the Quarter Ended September 2020	11/20/11	CI
Human Metabolome Technologies, Inc. Provides Financial Guidance for the Quarter Ending June 2021	11/20/11	CI
Human Metabolome Technologies, Inc. Announces Consolidated Earnings Results for the Year Ended June 30, 2020	14/20/14	CI
Human Metabolome Technologies, Inc. Provides Consolidated Earnings Guidance for the Full Year Ending June 30, 2021	14/20/14	CI
Human Metabolome Technologies, Inc. Announces Consolidated Earnings Results for the Third Quarter Ended March 2020; Provides Earnings Guidance for the Year Ending June 30, 2020	08/20/08	CI
Human Metabolome Technologies, Inc. Announces Consolidated Earnings Results for the Second Quarter Ended December 2019; Provides Consolidated Earnings Guidance for the Year Ending June 30, 2020	07/20/07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Human Metabolome Technologies, Inc.

Equities

6090

JP3794530000

Highlights

Filters